A conceptual multi-agent LLM architecture for pre-revenue biotech valuation is proposed, backed only by the author's unaudited fund returns and no implementation.
and Burger, Doug and Wang, Chi , title =
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
cs.MA 1years
2026 1verdicts
REJECT 1representative citing papers
citing papers explorer
-
Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology
A conceptual multi-agent LLM architecture for pre-revenue biotech valuation is proposed, backed only by the author's unaudited fund returns and no implementation.